Polymorphisms in the vitamin D receptor and risk of gout in Chinese Han male population

Rheumatology International

Volumn 35, Issue 6, 2015, Pages 963-971

  Liu, Shi Guo ^a   Li, Yuan Yuan ^a   Sun, Rui Xia ^a   Wang, Jing Li ^a   Li, Xin De ^a   Han, Lin ^a   Chu, Nan ^b   Li, Chang Gui ^a  

^a QINGDAO UNIVERSITY   (China)

^b Qingdao Hiser Hospital   (China)

Author keywords

Chinese Han population; Gout; Susceptibility; VDR

Indexed keywords

VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; VDR PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; GOUT; HAN CHINESE; HOST SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; CHINA; ETHNOLOGY; GENETIC ASSOCIATION STUDY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; ODDS RATIO; PHENOTYPE; RISK FACTOR; SEX DIFFERENCE;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHINA; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GOUT; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; RISK FACTORS; SEX FACTORS;

EID: 84939418249     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-014-3167-z     Document Type: Article

References (36)

1. Doherty M (2009) New insights into the epidemiology of gout. Rheumatology 48:2–8
2. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237–241
3. Yuan HJ, Yang XG, Shi XY, Tian R, Zhao ZG (2011) Association of serum uric acid with different levels of glucose and related factors. Chin Med J 124:1443–1448
4. Emmerson B (1998) Hyperlipidaemia in hyperuricaemia and gout. Ann Rheum Dis 57:509–510
5. Choi HK, De Vera MA, Krishnan E (2008) Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile. Rheumatology 47:1567–1570
6. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266–281
7. DeLuca HF (2004) Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 80:1689S–1696S
8. McCullough ML, Bostick RM, Mayo TL (2009) Vitamin D gene pathway polymorphisms and risk of colorectal, breast, and prostate cancer. Annu Rev Nutr 29:111–132
9. Hayes ME, Denton J, Freemont AJ, Mawer EB (1989) Synthesis of the active metabolite of vitamin D, 1,25(OH)2D3, by synovial fluid macrophages in arthritic diseases. Ann Rheum Dis 48:723–729
10. De Azevedo Silva J, Guimaraes RL, Brandao LA, Araujo J, Segat L et al (2013) Vitamin D receptor (VDR) gene polymorphisms and age onset in type 1 diabetes mellitus. Autoimmunity 46:382–387
11. Eisman JA (1999) Genetics of osteoporosis. Endocr Rev 20:788–804
12. Gu JM, Xiao WJ, He JW, Zhang H, Hu WW et al (2009) Association between VDR and ESR1 gene polymorphisms with bone and obesity phenotypes in Chinese male nuclear families. Acta Pharmacol Sin 30:1634–1642
13. Carling T, Kindmark A, Hellman P, Lundgren E, Ljunghall S et al (1995) Vitamin D receptor genotypes in primary hyperparathyroidism. Nat Med 1:1309–1311
14. Takahashi S, Yamamoto T, Moriwaki Y, Tsutsumi Z, Yamakita J et al (1998) Decreased serum concentrations of 1,25(OH)2-vitamin D3 in patients with gout. Adv Exp Med Biol 431:57–60
15. Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR Jr et al (2005) Gout epidemiology: results from the UK general practice research database, 1990–1999. Ann Rheum Dis 64:267–272
16. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237–241
17. Giamarellos-Bourboulis EJ, Mouktaroudi M, Bodar E, van der Ven J, Kullberg BJ et al (2009) Crystals of monosodium urate monohydrate enhance lipopolysaccharide-induced release of interleukin 1 beta by mononuclear cells through a caspase 1-mediated process. Ann Rheum Dis 68:273–278
18. Landis RC, Haskard DO (2001) Pathogenesis of crystal-induced inflammation. Curr Rheumatol Rep 3:36–41
19. Pouliot M, James MJ, McColl SR, Naccache PH, Cleland LG (1998) Monosodium urate microcrystals induce cyclooxygenase-2 in human monocytes. Blood 91:1769–1776
20. di Giovine FS, Malawista SE, Thornton E, Duff GW (1991) Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution. J Clin Invest 87:1375–1381
21. Di Giovine FS, Malawista SE, Nuki G, Duff GW (1987) Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1. J Immunol 138:3213–3218
22. Guerne PA, Terkeltaub R, Zuraw B, Lotz M (1989) Inflammatory microcrystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes. Arthritis Rheum 32:1443–1452
23. Liu S, Yin C, Chu N, Han L, Li C (2013) IL-8-251T/A and IL-12B 1188A/C polymorphisms are associated with gout in a Chinese male population. Scand J Rheumatol 42:150–158
24. Conen D, Wietlisbach V, Bovet P, Shamlaye C, Riesen W et al (2004) Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health 4:9
25. Oda E, Kawai R, Sukumaran V, Watanabe K (2009) Uric acid is positively associated with metabolic syndrome but negatively associated with diabetes in Japanese men. Intern Med 48:1785–1791
26. Onat A, Uyarel H, Hergenc G, Karabulut A, Albayrak S et al (2006) Serum uric acid is a determinant of metabolic syndrome in a population-based study. Am J Hypertens 19:1055–1062
27. Rho YH, Woo JH, Choi SJ, Lee YH, Ji JD et al (2008) Association between serum uric acid and the Adult Treatment Panel III-defined metabolic syndrome: results from a single hospital database. Metab Clin Exp 57:71–76
28. Rodrigues SL, Baldo MP, Capingana DP, Magalhaes P, Dantas EM et al (2012) Gender distribution of serum uric acid and cardiovascular risk factors: population based study. Arq Bras Cardiol 98:13–21
29. Hwu CM, Lin KH (2010) Uric acid and the development of hypertension. Med Sci Monit 16:Ra224–Ra230
30. Norman AW (2008) From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 88:491s–499s
31. Agrawal T, Gupta GK, Agrawal DK (2012) Vitamin D deficiency decreases the expression of VDR and prohibitin in the lungs of mice with allergic airway inflammation. Exp Mol Pathol 93:74–81
32. Sanchez-Nino MD, Bozic M, Cordoba-Lanus E, Valcheva P, Gracia O et al (2012) Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy. Am J Physiol Renal Physiol 302:F647–F657
33. El-Shal AS, Shalaby SM, Aly NM, Rashad NM, Abdelaziz AM (2013) Genetic variation in the vitamin D receptor gene and vitamin D serum levels in Egyptian women with polycystic ovary syndrome. Mol Biol Rep 40:6063–6073
34. Kottgen A, Albrecht E, Teumer A, Vitart V, Krumsiek J et al (2013) Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet 45:145–154
35. Uitterlinden AG, Fang Y, van Meurs JBJ, Pols HAP, van Leeuwen JPTM (2004) Genetics and biology of vitamin D receptor polymorphisms. Gene 338:143–156
36. Bai YH, Lu H, Hong D, Lin CC, Yu Z et al (2012) Vitamin D receptor gene polymorphisms and colorectal cancer risk: a systematic meta-analysis. World J Gastroenterol 18:1672–1679